Kenvue, the American pharmaceutical firm behind the well-known paracetamol brand Tylenol, has been acquired for $49 billion (£37 billion) by consumer goods conglomerate Kimberly-Clark. The deal follows a tumultuous period
Kenvue, the American pharmaceutical firm behind the well-known paracetamol brand Tylenol, has been acquired for $49 billion (£37 billion) by consumer goods conglomerate Kimberly-Clark. The deal follows a tumultuous period






